VINCENT JAMES L 4
4 · ALNYLAM PHARMACEUTICALS, INC. · Filed Jun 18, 2010
Insider Transaction Report
Form 4
VINCENT JAMES L
Director
Transactions
- Sale
Common Stock
2010-06-18$15.16/sh−8,667$131,392→ 0 total - Sale
Common Stock
2010-06-17$15.70/sh−1,333$20,930→ 8,667 total - Sale
Common Stock
2010-06-18$15.19/sh−12,100$183,826→ 0 total - Exercise/Conversion
Common Stock
2010-06-18$7.02/sh+12,100$84,942→ 12,100 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2010-06-18−12,100→ 0 totalExercise: $7.02Exp: 2015-07-12→ Common Stock (12,100 underlying)
Footnotes (1)
- [F1]The stock option vested as to one third of the shares on each of the first, second and third anniversaries of the grant date.